VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $17,512,000 | -22.0% | 1,100,000 | +1.9% | 0.00% | -20.0% |
| Q4 2017 | $22,442,000 | +2.9% | 1,080,000 | +548.6% | 0.01% | -16.7% |
| Q3 2014 | $21,817,000 | +36.4% | 166,500 | +31.6% | 0.01% | +50.0% |
| Q2 2014 | $15,997,000 | +5.7% | 126,500 | +10.0% | 0.00% | 0.0% |
| Q1 2014 | $15,129,000 | +12.1% | 115,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $13,491,000 | +12.5% | 115,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $11,991,000 | – | 115,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |